Better-than-expected sales helped Biogen regain the support of investors, while AstraZeneca and GSK worked to convince Wall Street that they can hit ambitious revenue targets.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
KeyBanc expects Reddit’s investments in community engagement and advertising monetization to create a durable business capable of generating annual revenue growth above 30%.
United Microelectronics (NYSE:UMC) reported higher second-quarter revenue, wafer shipments and utilization as demand strengthened in communications and consumer applications, while the company raised its 2026 capital-expenditure budget to support silicon photonics and advanced-packaging growth initi
KLA Corporation (NASDAQ:KLAC) reported stronger-than-expected fiscal fourth-quarter results, but its shares fell more than 10% in pre-market trading on Wednesday after investors focused on a cautious near-term outlook and guidance that offered only limited upside. The semiconductor equipment manufacturer posted earnings per share of $1.
Biogen’s growth portfolio, which includes one closely watched Alzheimer’s drug, is a bright spot in the second quarter.
There’s never a good time to miss on earnings, but memory-chip giant SK Hynix really picked its moment.
Options traders expect a roughly $190 billion swing in Microsoft's market value after it reports earnings on Wednesday, an unusually large move that underscores investors' growing eagerness to see if billions of dollars in AI spending are beginning to pay off. By comparison, over the last 12 earnings cycles, Microsoft has averaged a 4.8% implied move and a 4.4% actual move, Option Research & Technology Services (ORATS) data showed. The significantly higher pricing this quarter suggests that investors view Microsoft — one of the hyperscalers whose massive AI capital spending is at the heart of this year's AI rally and the broader bull market — as central to the AI earnings story.
Tech giant Microsoft is set to report earnings today after the market close, and investors will be listening to hear whether the company expects to maintain the rapid growth at its cloud business, Azure. In its last quarterly earnings call, Microsoft said it expected roughly $190 billion in capex this calendar year, but the firm only spent about $30 billion in the first three months of the year. Microsoft shares closed up 1.1% yesterday, but they are 19% lower so far this year.
Meta stock has declined for nine consecutive sessions, falling about 13% cumulatively.
UBS Group (NYSE:UBS) reported second-quarter 2026 net profit of CHF 2.8 billion and earnings per share of CHF 0.87, as growth in wealth management and the investment bank helped lift underlying pre-tax profit by 45% from a year earlier to CHF 3.9 billion. Group Chief Executive Officer Sergio Ermott
Dillard's currently trades at $573.95 per share and has shown little upside over the past six months, posting a small loss of 4.9%. The stock also fell short of the S&P 500’s 6.3% gain during that period.
What a time it’s been for DaVita. In the past six months alone, the company’s stock price has increased by a massive 122%, reaching $235.17 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Skyworks Solutions Inc (SWKS) surpasses revenue expectations, announces a $2 billion stock repurchase program, and anticipates a promising Qorvo combination.
Enphase Energy Inc (ENPH) reports robust gross margins and strategic product launches, despite facing headwinds in the US market.
Tilray Brands Inc (TLRY) reports significant financial improvements and outlines strategic plans for future expansion across diverse sectors.
Despite a net loss, Ford Motor Co (F) raises full-year guidance, showcasing confidence in its strategic initiatives and strong product mix.
KLA Corp (KLAC) achieves record revenue of $3.66 billion, driven by AI infrastructure demand, while navigating supply chain and pricing pressures.
Visa Inc (V) reports a robust 14% increase in net revenue, driven by strong payments volume and innovative solutions, despite rising expenses and market uncertainties.
Bloom Energy Corp (BE) achieves its first $1 billion quarter, expands partnerships, and raises full-year guidance amid robust demand and market leadership.
As investors await Microsoft Corp’s (NASDAQ:MSFT) quarterly results, Gene Munster argues the company’s long-term AI strategy—not its near-term earnings—will determine whether it can maintain its market leadership. Munster Says Microsoft’s AI Transition Matters More Than Earnings Ahead of Microsoft’s earnings report on Wednesday, Deepwater Asset Management’s managing partner said that Wall Street is focused on the wrong metric, arguing that the software giant’s biggest challenges lie years ahead
AbbVie(ABBV) reports second-quarter results on Friday, July 31, and the mood around the stock has changed. A few months ago, investors were restless. The two drugs carrying the company were doing fine, but everyone already knew that, and the market wanted a new reason to invest. Goldman Sachs went ...
Corning is best known for Gorilla Glass, the durable material used in smartphone screens. The company also makes the optical fiber, cables, and connectors that move data among thousands of processors inside artificial intelligence data centers. That business helped more than double Corning’s share ...
Sanjeev Rana, head of research at CLSA Securities Korea, believes Hynix's earnings miss was the result of a weak product mix in the second quarter, and he expects "sequential earnings improvement." Meanwhile, KB Financial Group Global Investment Strategist Peter Kim shares his takes on the underlying trends driving the selloff in AI stocks.
Conflict in the Middle East escalated again – the U.S. said that Iranian forces had attacked the American military on Tuesday evening.
The headline numbers for Seagate (STX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sarah London discusses margin expansion and dual-eligible Medicare focus.
The memory maker's two valuation multiples describe two different companies. Believing the cheap one requires one big assumption.